Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Mon, 13 May 2024

Trading levels for OCGN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.74 9.64 %
R2 1.69 6.28 %
R1 1.66 4.20 %
Current price: 1.59
Support S1 1.55 -2.52 %
S2 1.52 -4.60 %
S3 1.46 -7.97 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.83 15.09 %
R2 1.73 8.81 %
R1 1.64 3.14 %
Current price 1.59
Support S1 1.34 -15.72%
S2 1.32 -16.98%
S3 1.24 -22.01%

OCGN Predictions History

2 years ago
ngbots predicted that OCGN for 2021-10-19 is going

2 years ago
jameslab762.261805 predicted that OCGN for 2021-10-19 is going

Rank:

2 years ago
specialized.venge2019.262743 predicted that OCGN for 2021-10-19 is going

Rank:

2 years ago
JS predicted that OCGN for 2021-10-07 is going $6.91 (-2.54%)

2 years ago
Rybkarybka predicted that OCGN for 2021-10-07 is going $6.96 (-1.83%)

2 years ago
codyfinancial28.262438 predicted that OCGN for 2021-10-07 is going $7.15 (5.15%)

Rank:

2 years ago
JS predicted that OCGN for 2021-10-06 is going $7.01 (3.09%)

2 years ago
emt predicted that OCGN for 2021-10-06 is going

Rank:

2 years ago
RamboRex3000 predicted that OCGN for 2021-08-23 is going $7.35 (-3.92%)

2 years ago
JS predicted that OCGN for 2021-08-23 is going $7.46 (-2.48%)

Click to get the best stock tips daily for free!

About Ocugen Inc

Ocugen Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related ... OCGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT